Skip to the main content.
Facebook Instagram Linkedin X YouTube Medium

megamenu-services

 

Turn Vision into Velocity with the Innovation CRO

Traditional CROs fragment device development with costly hand-offs and learning curves. Veranex unites the essential disciplines for medical device & diagnostic development under one roof from sketch to evidence-generation to market launch.

All connected. All aligned. All accelerating your path to market—delivering breakthrough devices and diagnostics that improve patient lives sooner.

Explore our Services

megamenu-solutions-expertise

 

Outcome-Driven Solutions for Medtech Challenges

Breakthrough innovation requires more than great solutions; it demands deep expertise and insight. Veranex packages outcome-driven solutions with 25+ years of specialized knowledge across major medtech categories, delivering integrated capabilities that solve your most pressing challenges faster and with greater certainty.

Purpose-built solutions. Proven results. User & Patient-centered innovation.

 

Solutions
Expertise

megamenu-company-2

 

Purpose-Built for Breakthroughs

Whether you're transforming patient care or disrupting entire therapeutic categories, innovation requires more than great science, it demands velocity.  Veranex was founded to bridge the gap between visionary concepts and market reality, combining proven expertise with agile execution to accelerate the innovations that matter most.  

We are the Innovation CRO.

Legacy of excellence. Proven execution. Patient impact accelerated.

 

Explore our Company

megamenu-company-2

Turn Our Insights Into Your Impact

From early feasibility to commercialization, progress depends on the right decisions at the right time. Get confident in your next step with blogs, case studies, and expert insights that cut through complexity and move development forward.

 

Explore our Resources

Veranex Blog

Preclinical

6 min read

Optimizing Preclinical Studies for Clinical Trials and Market Adoption

Picture of Jennifer Gordon Jennifer Gordon: Aug 12, 2026, 8:00:01 AM
Clinical Research Preclinical Device CRO
Read More
Preclinical Success Recross Cardio

6 min read

Preclinical Precision Enables First-in-Human Trials for Recross Cardio's Novel PFO Sealing Technology

Picture of Nicolas Borenstein Nicolas Borenstein: Aug 5, 2026, 7:30:00 AM
Cardiovascular Preclinical
Read More

5 min read

Closing the Imaging Gap in Preclinical Neurosurgery

Picture of Olivier Chevenement Olivier Chevenement: Jul 15, 2026, 8:00:00 AM
Neurovascular Preclinical
Read More

5 min read

A New Chapter for the Heart Valve: Foldax's TRIA™ TAVR Promising Preclinical Results in npj Cardiovascular Health

Picture of Nicolas Borenstein Nicolas Borenstein: Jun 24, 2026, 8:00:00 AM
Cardiovascular Preclinical
Read More

5 min read

Three Nightmare Preclinical Study Failures Histopathology Could Have Prevented

Picture of Kate San Souci Kate San Souci: Jun 3, 2026, 8:00:03 AM
Preclinical Pathology/Histology
Read More

5 min read

Five Signs You're Not Ready for GLP Preclinical Studies

Picture of Michael Sweet Michael Sweet: Apr 15, 2026, 8:00:02 AM
Preclinical
Read More

6 min read

Six Signs You're Not Ready for GLP Preclinical Studies - A Histology Perspective

Picture of Kirsten Landsgaard, BVMS, MRCVS, MS, DACVP Kirsten Landsgaard, BVMS, MRCVS, MS, DACVP: Apr 8, 2026, 8:00:00 AM
Preclinical Pathology/Histology
Read More

4 min read

6 Pitfalls In Selecting KOLs for Preclinical Medical Device Studies

Picture of Nicolas Borenstein Nicolas Borenstein: Feb 4, 2026, 8:00:02 AM
Preclinical Device CRO
Read More

6 min read

Exposed! How Histopathology Reveals Critical GLP Study Failures

Picture of Kirsten Landsgaard, BVMS, MRCVS, MS, DACVP Kirsten Landsgaard, BVMS, MRCVS, MS, DACVP: Jan 21, 2026, 8:15:01 AM
Preclinical Pathology/Histology
Read More

6 min read

Five Costly Misconceptions About GLP Studies (And Why They Matter)

Picture of Michael Sweet Michael Sweet: Jan 14, 2026, 8:15:01 AM
Preclinical
Read More
1 2 3 Next